首页 | 本学科首页   官方微博 | 高级检索  
     


The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study
Authors:David K. Hooper  Jason C. Williams  Adam C. Carle  Sandra Amaral  Deepa H. Chand  Maria E. Ferris  Hiren P. Patel  Christoph Licht  Gina-Marie Barletta  Veronica Zitterman  Mark Mitsnefes  Uptal D. Patel
Affiliation:1. Division of Nephrology & Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
3. James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
2. Pediatric Nephrology, Duke Children’s Hospital & Health Center, Durham, NC, USA
4. Pediatric Nephrology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
5. Pediatric Nephrology, Rush Children’s Hospital, Chicago, IL, USA
6. Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
7. Pediatric Nephrology, Nationwide Children’s Hospital, Columbus, OH, USA
8. Pediatric Nephrology, Hospital for Sick Children, Toronto, ON, Canada
9. Division of Pediatric Nephrology, Phoenix Children’s Hospital, Phoenix, AZ, USA
10. University of Michigan, Ann Arbor, MI, USA
11. Duke Clinical Research Institute, 2400 Pratt Street, P.O. Box 3646, Nephrology, Durham, NC, 27705, USA
Abstract:

Background

Cardiovascular disease is the leading cause of increased mortality for adolescents with advanced kidney disease. The quality of preventive cardiovascular care may impact long-term outcomes for these patients.

Methods

We reviewed the records of 196 consecutive adolescents from eight centers with pre-dialysis chronic kidney disease, on dialysis or with a kidney transplant, who transferred to adult-focused providers. We compared cardiovascular risk assessment and therapy within and across centers. Predictors of care were assessed using multilevel models.

Results

Overall, 58 % (range 44–86 %; p?=?0.08 for variance) of five recommended cardiovascular risk assessments were documented. Recommended therapy for six modifiable cardiovascular risk factors was documented 57 % (26–76 %; p?=?0.09) of the time. Of these patients, 30 % (n?=?59) were reported to go through formal transition which was independently associated with a 21 % increase in composite cardiovascular risk assessment (p?p?p?=?0.045, respectively).

Conclusions

Adolescents with kidney disease receive suboptimal preventive cardiovascular care, that may contribute to their high risk of future cardiovascular mortality. A great opportunity exists to improve outcomes for children with kidney disease by improving the reliability of preventive care that may include formal transition programs.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号